CyberCare Health Network Signs New Contract With Primary Wound Care Specialists LLC

NORTH PALM BEACH, FL--(Marketwire - Sep 11, 2012) - EncounterCare Solutions (PINKSHEETS: ECSL) announced today that its subsidiary, CyberCare Health Network, Inc. ("CyberCare"), has signed a three year contract with Primary Wound Care Specialists LLC to supply an integrated clinical solution for wound management. This solution integrates two systems, CyberCare's Electronic House Call Technology and ARANZ Medical's Silhouette Wound Assessment and Information System. This joint solution enables the comprehensive assessment, treatment planning and compliance monitoring for patients enrolled in Primary Wound Care's contracted Health Plans.

"The introduction of this new wound management program is a significant milestone for CyberCare," stated Chris Doherty, Executive Vice President of CyberCare. "Wound care is a large cost factor in health care today and this novel wound care treatment system will decrease costs while enhancing wound management and patient care. We expect that this relationship with Primary Wound will develop into an increasingly profitable market opportunity for CyberCare."

CyberCare's Electronic House Call allows the clinician to record the data from ARANZ Medical's Silhouette system, compile compliance data and transmit it back to a central station for review by clinical experts. The Electronic House Call allows both the clinician and the patient to review both objective and subjective data that is applicable to both patient compliance and the prescribed care plan so as to improve patient outcomes.

The ARANZ Silhouette Wound Assessment and Information System is a new product that images, measures and documents wounds and provides decision support capabilities for wound care professionals. Measurements require no physical contact with the patient, eliminating discomfort and reducing risk of infection and are incorporated directly into the patient's electronic medical record. Presentation of near-real time data on wound progress at the point-of-care allows more informed and timely decisions on treatment pathways and its comprehensive reporting and analysis capabilities allow providers and payers to track and report on therapy utilization, healing outcomes and compliance with prescribed care plans.

About EncounterCare Solutions:

EncounterCare Solutions, Inc. (PINKSHEETS: ECSL), headquartered in Palm Beach Gardens, Florida, is an integrated Healthcare and Energy company that operates its business through three divisions, the Healthcare Technology Division, the Healthcare Services Division, and the Energy Division. The Company's health care businesses offer a broad range of proprietary healthcare technology, products and services that address several substantial target markets including the Healthcare Information Technology Market, the Healthcare Telemedicine Market and the Homecare Market. The Company's energy business consists of its CyberFuel unit which produces and distributes a fuel additive that enhances the capabilities of a range of existing fuel products by cooling the exhaust gases resulting from engine combustion. CyberFuel's Singular 96™ product lowers the overall cost of fuel, increases engine efficiency and enables the further utilization of methanol while significantly lowering the emission of dangerous gases into the environment. For more information, visit the Company's website at www.EncounterCare.com.

About ARANZ Medical:

ARANZ Medical Limited is focused on the development and marketing of the Silhouette Product Suite for advanced wound assessment and wound information management. Silhouette resulted from listening to and working with customers, recognizing that a simple technology-based solution could be created, allowing more efficient and integrated wound documentation with superior outcomes. Employing technology derived from a laser scanning solution developed by ARANZ and employed in the creation of the Lord of the Rings movie trilogy, Silhouette has proven its effectiveness and accuracy through extensive use in more than 25 countries for clinical practice and multi-centre clinical studies. For more information, visit the company's website at www.aranzmedical.com.

About Primary Wound Care:

Primary Wound Care Specialists has been providing wound care services in Dade, Broward, and Palm Beach counties since 2009. Their physicians and medical staff are trained in advanced and other wound care specialties. They offer a customized treatment plan to meet the patient's individual needs. Clinicians with extensive training in advanced wound care techniques have the leading edge wound care modalities. A comprehensive management plan offers a complete Electronic Medical Record (EMR). For more information, visit the company's website at www.priwc.com.

Safe Harbor:

Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Federal Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intends," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, including but not limited to, economic conditions, dependence on management, dilution to shareholders, lack of capital changes in laws or regulations, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth, demand for products and services of the Company, newly developing technologies, its ability to compete, conflicts of interest related to party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition, and the ability of the Company to obtain additional financing. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.